skip to content
  1. Home
  2. >
  3. Investment Q&A
You can view 3 more answers this month. Sign up for a free trial for unlimited access.

Investment Q&A

Not investment advice or solicitation to buy/sell securities. Do your own due diligence and/or consult an advisor.

Q: I have been following Eye Carrot since last six months. It got my eyes after Fabrice Taylor recommended it on BNN as a buy at around $0.27. Stock is now trading at $0.02, below it's net book value of $0.04. According to last financials, company has good cash but recent year end financials got delayed, i think, due to law suit going on between CEO not paying salary to ex CFO. Company is doing a lot of promotions of technology, but I am not sure about POs/potential revenue. I am looking to trade this super risky share since it is trading below Net Book Value, but I am concerned about bankruptcy and year end financials. What are your thoughts about it?
Read Answer Asked by Rahil on July 03, 2019
Q: Wondering what your thoughts are on ABM:CA now that they are diversifying into the gravel industry? Tks so much for your excellant service. Glynn Norman
Read Answer Asked by Glynn on July 02, 2019
Q: There is currently a lot of hype around Abm (again ). What have you heard and what is your opinion??
Read Answer Asked by michael on June 28, 2019
Q: Hey,
I’m down 20% on Photon right now, it makes up just over 2% of the account it’s in and around .5% of total portfolio. I held through it’s great run up last then watched it fall lower than I started. Are you confident enough in another future run to look at the price now as a good chance to average down? Or is it too speculative and I should just hold now and be patient.
Thanks
Read Answer Asked by david on June 27, 2019
Q: Hi,

Would you consider doing a report on AT-Acuity Ads? Your analysis on this stock is much appreciated. How is their balance sheet, cash flow, debt level, management and their product. Peter's article in the Financial Post got me interested in AT because I sold TTD rather prematurely (and I am kicking myself) ..Would you recommend one to buy the same stock (TTD) at a higher price or consider its little brother?
Read Answer Asked by Shyam on June 24, 2019
Q: What is 5i's thoughts about Sangoma's bought deal financing announced this morning at $1.55. Despite the dilution is it good for current shareholders given the Company's track record? Will it improve valuation metrics (trading multiples) going forward? Currently Sangoma trades less then 1X sales which seems very cheap against their peer group and other small caps.
Read Answer Asked by Charles on June 24, 2019